The new nasal vaccine only needs one dose and produces reliable immunity right at the site where the virus enters the body.

plan to use the grant funding to adapt the nasal spray technology they originally developed for COVID-19 and human influenza. The vaccine could also potentially be used in humans, if necessary ...

Scientists have pioneered an influenza virus vector-based nasal spray vaccine platform and developed a nasal spray H5N1 avian influenza vaccine. During the early COVID-19 pandemic, this platform ...